Breadcrumb

Naris  Nilubol, M.D., F.A.C.S.

Naris Nilubol, M.D., F.A.C.S.

  • Center for Cancer Research
  • National Cancer Institute
Senior Research Physician
Surgical Oncology Program
Head, Targeted Therapy in Endocrine Cancers Section

RESEARCH SUMMARY

Dr. Nilubol is a surgeon-scientist specialized in endocrine oncology surgery and clinical research involving thyroid, parathyroid, adrenal, and neuroendocrine tumors. His laboratory research focus includes the identification of novel targeted therapeutics in endocrine cancers and novel cancer drug delivery methods by targeting tumor microenvironment.

Areas of Expertise

Rare Tumors
Endocrine Surgery
Novel Therapeutics In Endocrine Cancers
Cancer Drug Delivery
Cancer Drug Discovery

Information for Patients

Learn more about our clinical trials and the highly specialized care teams that lead them. 

Publications

Selected Recent Publications

Novel Dual-Action Targeted Nanomedicine in Mice With Metastatic Thyroid Cancer and Pancreatic Neuroendocrine Tumors

Nilubol N, Yuan Z, Paciotti GF, Tamarkin L, Sanchez C, Gaskins K, Freedman EM, Cao S, Zhao J, Kingston DGI, Libutti SK, Kebebew E.
J Natl Cancer Inst. 110(9): 1019-1029, 2018. [ Journal Article ]

Synergistic combination of flavopiridol and carfilzomib targets commonly dysregulated pathways in adrenocortical carcinoma and has biomarkers of response

Nilubol N, Boufraqech M, Zhang L, Gaskins K, Shen M, Zhang YQ, Gara SK, Austin CP, Kebebew E.
Oncotarget. 9(68): 33030-33042, 2018. [ Journal Article ]

Targeting the invincible barrier for drug delivery in solid cancers: interstitial fluid pressure

Libutti SK, Tamarkin L, Nilubol N.
Oncotarget. 9(87): 35723-35725, 2018. [ Journal Article ]

High prevalence of chronic kidney disease in patients with multiple endocrine neoplasia type 1 and improved kidney function after parathyroidectomy

Green P, Zagzag J, Patel D, Weinstein LS, Simonds WF, Blau J, Marx S, Kebebew E, Perrier N, Nilubol N.
Surgery. 165(1): 124-128, 2019. [ Journal Article ]

Lysyl Oxidase Is a Key Player in BRAF/MAPK Pathway-Driven Thyroid Cancer Aggressiveness

Boufraqech M, Patel D, Nilubol N, Powers A, King T, Shell J, Lack J, Zhang L, Gara SK, Gunda V, Klubo-Gwiezdzinska J, Kumar S, Fagin J, Knauf J, Parangi S, Venzon D, Quezado M, Kebebew E.
Thyroid. 29(1): 79-92, 2018. [ Journal Article ]

Team

Postdoctoral Fellow (Visiting)
Dipranjan Laha, Ph.D.
Research Nurse
Kristine Joy Villaruel
Patient Care Coordinator (Contr.)
Elizabeth Martin
Program Specialist
Anna Coxen
Clinical Research Fellow
Bhavishya Ramamoorthy